Torno Capital, LLC Reneo Pharmaceuticals, Inc. Call Options Transaction History
Torno Capital, LLC
- $1.56 Trillion
- Q1 2024
Call Options
2 transactions
Others Institutions Holding RPHM
# of Institutions
69Shares Held
29.4MCall Options Held
125KPut Options Held
3.1K-
Nea Management Company, LLC Timonium, MD4.79MShares$7.18 Million0.56% of portfolio
-
Tang Capital Management LLC San Diego, CA3MShares$4.5 Million0.61% of portfolio
-
Highbridge Capital Management LLC New York, NY2.74MShares$4.1 Million1.03% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$4.05 Million0.33% of portfolio
-
River Vest Venture Management LLC St. Louis, MO2.53MShares$3.8 Million56.07% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $36.7M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...